切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2025, Vol. 14 ›› Issue (04) : 549 -553. doi: 10.3877/cma.j.issn.2095-3232.2025.04.008

临床研究

ICG荧光显影在腹腔镜肝癌切除术中临床应用
王楚斯, 刘家伟, 卢逸, 汤照峰()   
  1. 510630 广州,中山大学附属第三医院肝胆外科
  • 收稿日期:2025-02-06 出版日期:2025-08-10
  • 通信作者: 汤照峰
  • 基金资助:
    广州市科技计划项目(202102010309)

Clinical application of ICG fluorescence imaging in laparoscopic hepatectomy for hepatocellular carcinoma

Chusi Wang, Jiawei Liu, Yi Lu, Zhaofeng Tang()   

  1. Department of Hepatobiliary Surgery, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China
  • Received:2025-02-06 Published:2025-08-10
  • Corresponding author: Zhaofeng Tang
引用本文:

王楚斯, 刘家伟, 卢逸, 汤照峰. ICG荧光显影在腹腔镜肝癌切除术中临床应用[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(04): 549-553.

Chusi Wang, Jiawei Liu, Yi Lu, Zhaofeng Tang. Clinical application of ICG fluorescence imaging in laparoscopic hepatectomy for hepatocellular carcinoma[J/OL]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2025, 14(04): 549-553.

目的

探究ICG荧光显影技术在腹腔镜肝细胞癌(肝癌)切除术中的临床应用安全性和疗效。

方法

回顾性分析2023年1月至2024年1月在中山大学附属第三医院行腹腔镜肝癌切除术的患者47例患者临床资料。患者均签署知情同意书,符合医学伦理学规定。其中男40例,女7例;平均年龄(57±11)岁。根据是否采用ICG荧光显影技术,将患者分为ICG组(21例)和传统组(26例)。两组手术时间、术中出血量比较采用秩和检验,两组肿瘤切缘及术后并发症等比较采用χ2检验或Fisher确切概率法。

结果

两组患者均在腹腔镜下完成肝癌切除术,无中转开腹。ICG组肿瘤切缘≥1 cm者16例,传统组7例,差异有统计学意义(χ2=11.284,P<0.05)。ICG组手术时间、术中出血量、术后住院时间分别为163(140,198)min、50(50,100)ml、4.0(4.0,5.5)d,传统组相应为170(134,226)min、50(28,100)ml、5.5(3.0,7.0)d,差异无统计学意义(Z=0.857,0.801,-1.083;P>0.05)。ICG组术后胆漏、腹腔积液分别为0、1例,传统组相应为4、0例,差异均无统计学意义(P>0.05)。

结论

与传统腹腔镜肝癌切除术相比,ICG荧光显影技术能够帮助术者获得更理想的肿瘤切缘距离,且并未增加手术时间及手术风险。

Objective

To evaluate clinical efficacy and safety of ICG fluorescence imaging in laparoscopic hepatectomy of hepatocellular carcinoma (HCC).

Methods

Clinical data of 47 patients who underwent laparoscopic hepatectomy of HCC in the Third Affiliated Hospital of Sun Yat-sen University from January 2023 to January 2024 were retrospectively analyzed. The informed consents of all patients were obtained and the local ethical committee approval was received. Among them, 40 patients were male and 7 female, aged (57±11) years on average. All patients were divided into ICG group (n=21) and traditional group (n=26) according to whether ICG fluorescence imaging was used. Operation time and intraoperative blood loss between two groups were compared by rank-sum test. Tumor margin and the incidence of postoperative complications between two groups were compared by Chi-square test or Fisher’s exact test.

Results

All HCC patients in two groups underwent laparoscopic hepatectomy without conversion to open surgery. In the ICG group, the tumor margin was ≥1 cm in 16 cases and 7 cases in the traditional group, and the difference was statistically significant (χ2=11.284, P<0.05). In the ICG group, the operation time, intraoperative blood loss and the length of postoperative hospital stay were 163 (140, 198) min, 50 (50, 100) ml and 4.0 (4.0, 5.5) d, respectively, compared with 170 (134, 226) min, 50 (28,100) ml and 5.5 (3.0,7.0) d in traditional group, and the differences were not statistically significant (Z=0.857, 0.801, -1.083; all P>0.05). In the ICG group, no postoperative bile leakage and 1 case of peritoneal effusion was observed, while 4 and 0 in the traditional group, and the difference was not statistically significant (both P>0.05).

Conclusions

Compared with traditional laparoscopic resection of HCC, ICG fluorescence imaging can assist surgeons to obtain more favorable tumor margin without prolonging operation time or increasing surgical risk.

表1 两组肝癌腹腔镜肝切除患者术前一般资料比较
图1 一例ICG荧光显影技术在腹腔镜肝癌切除术中应用情况注:a为术中使用ICG荧光显影技术定位肝癌,根据肝癌荧光显影标记切除线;b为术中使用ICG荧光显影技术观察切缘情况;c为使用ICG荧光显影技术观察肝断面有无肿瘤残留;d为使用ICG荧光显影技术观察肿瘤切缘距离
表2 两组肝癌腹腔镜肝切除患者围手术期情况比较[MQ1Q3)]
[1]
Zhou M, Wang H, Zeng X, et al. Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017[J]. Lancet, 2019, 394(10204): 1145-1158. DOI: 10.1016/S0140-6736(19)30427-1.
[2]
Boni L, David G, Mangano A, et al. Clinical applications of indocyanine green (ICG) enhanced fluorescence in laparoscopic surgery[J]. Surg Endosc, 2015, 29(7): 2046-2055. DOI: 10.1007/s00464-014-3895-x.
[3]
Wen T, Jin C, Facciorusso A, et al. Multidisciplinary management of recurrent and metastatic hepatocellular carcinoma after resection: an international expert consensus[J]. Hepatobiliary Surg Nutr, 2018, 7(5): 353-371. DOI: 10.21037/hbsn.2018.08.01.
[4]
肝癌术后辅助治疗中国专家共识协作组, 中国医师协会外科医师分会, 中国抗癌协会肝癌专业委员会, 等. 肝癌术后辅助治疗中国专家共识(2023版)[J]. 中华消化外科杂志, 2023, 22(4): 437-448. DOI: 10.3760/cma.j.cn115610-20230315-00108.
[5]
倪俊声, 周伟平. 以切缘为本的肝切除是提高原发性肝癌生存率的关键[J]. 肝胆外科杂志, 2020, 28(2): 87-90. DOI: 10.3969/j.issn.1006-4761.2020.02.004.
[6]
Tsilimigras DI, Sahara K, Moris D, et al. Effect of surgical margin width on patterns of recurrence among patients undergoing R0 hepatectomy for T1 hepatocellular carcinoma: an international multi-institutional analysis[J]. J Gastrointest Surg, 2020, 24(7): 1552-1560. DOI: 10.1007/s11605-019-04275-0.
[7]
中华人民共和国国家卫生健康委员会医政司.原发性肝癌诊疗指南(2024年版)[J/OL].中华肝脏外科手术学电子杂志, 2024, 13(4): 407-449.DOI: 10.3877/cma.j.issn.2095-3232.2024.04.001.
[8]
Verma A, Maram J, Alagorie AR, et al. Distribution and location of Vortex vein ampullae in healthy human eyes as assessed by ultra-widefield indocyanine green angiography[J]. Ophthalmol Retina, 2020, 4(5): 530-534. DOI: 10.1016/j.oret.2019.11.009.
[9]
中华医学会数字医学分会, 中国医师协会肝癌专业委员会, 中国医师协会外科医师分会微创外科医师委员会, 等. 数字智能联合吲哚菁绿分子荧光导航肝切除术中国专家共识(2021年版)[J]. 中国实用外科杂志, 2022, 42(3): 274-284. DOI: 10.19538/j.cjps.issn1005-2208.2022.03.02.
[10]
Ishizawa T, Fukushima N, Shibahara J, et al. Real-time identification of liver cancers by using indocyanine green fluorescent imaging[J]. Cancer, 2009, 115(11): 2491-2504. DOI: 10.1002/cncr.24291.
[11]
Nishino H, Hatano E, Seo S, et al. Real-time navigation for liver surgery using projection mapping with indocyanine green fluorescence: development of the novel medical imaging projection system[J]. Ann Surg, 2018, 267(6): 1134-1140. DOI: 10.1097/SLA.0000000000002172.
[12]
姚舜禹, 荚卫东, 葛勇胜, 等. 吲哚氰绿荧光示踪技术在肝癌解剖性肝切除中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2019, 8(3): 221-225. DOI: 10.3877/cma.j.issn.2095-3232.2019.03.010.
[13]
Beger HG, Nakao A, Mayer B, et al. Duodenum-preserving total and partial pancreatic head resection for benign tumors—systematic review and meta-analysis[J]. Pancreatology, 2015, 15(2): 167-178. DOI: 10.1016/j.pan.2015.01.009.
[14]
Spinoglio G, Bertani E, Borin S, et al. Green indocyanine fluorescence in robotic abdominal surgery[J]. Updates Surg, 2018, 70(3): 375-379. DOI: 10.1007/s13304-018-0585-6.
[15]
方驰华, 刘允怡, 周伟平, 等. 数字医学技术在中国普通外科应用的十年回顾[J]. 中华外科杂志, 2017, 55(12): 887-890. DOI: 10.3760/cma.j.issn.0529-5815.2017.12.002.
[16]
Baiocchi GL, Diana M, Boni L. Indocyanine green-based fluorescence imaging in visceral and hepatobiliary and pancreatic surgery: state of the art and future directions[J]. World J Gastroenterol, 2018, 24(27): 2921-2930. DOI: 10.3748/wjg.v24.i27.2921.
[17]
中国研究型医院学会微创外科学专业委员会,《腹腔镜外科杂志》.吲哚菁绿荧光染色在腹腔镜肝切除术中应用的专家共识[J]. 腹腔镜外科杂志,2019,24(5):388-394. DOI: 10.13499/j.cnki.fqjwkzz.2019.05.388.
[18]
Majlesara A, Golriz M, Hafezi M, et al. Indocyanine green fluorescence imaging in hepatobiliary surgery[J]. Photodiagnosis Photodyn Ther, 2017, 17: 208-215. DOI: 10.1016/j.pdpdt.2016.12.005.
[19]
Abo T, Nanashima A, Tobinaga S, et al. Usefulness of intraoperative diagnosis of hepatic tumors located at the liver surface and hepatic segmental visualization using indocyanine green-photodynamic eye imaging[J]. Eur J Surg Oncol, 2015, 41(2): 257-264. DOI: 10.1016/j.ejso.2014.09.008.
[20]
Masuda K, Kaneko J, Kawaguchi Y, et al. Diagnostic accuracy of indocyanine green fluorescence imaging and multidetector row computed tomography for identifying hepatocellular carcinoma with liver explant correlation[J]. Hepatol Res, 2017, 47(12): 1299-1307. DOI: 10.1111/hepr.12870.
[21]
Ishizawa T, Masuda K, Urano Y, et al. Mechanistic background and clinical applications of indocyanine green fluorescence imaging of hepatocellular carcinoma[J]. Ann Surg Oncol, 2014, 21(2): 440-448. DOI: 10.1245/s10434-013-3360-4.
[22]
Ishizawa T, Kokudo N. Identification of hepatocellular carcinoma[M]//Fluorescent Imaging. Basel: S. Karger AG, 2013: 10-17. DOI: 10.1159/000348601.
[23]
中华医学会数字医学分会,中国研究型医院学会数字医学临床外科专业委员会,中国图学学会医学图像与设备专业委员会, 等. 计算机辅助联合吲哚菁绿分子荧光影像技术在肝脏肿瘤诊断和手术导航中的应用专家共识[J]. 中国实用外科杂志, 2017, 37(5): 531-538. DOI: 10.19538/j.cjps.issn1005-2208.2017.05.18.
[1] 孙丕绛, 崔上, 杨永君, 冉超, 王槐志. 腹腔镜下肠系膜上动脉优先入路联合门静脉切除重建扩大清扫胰十二指肠切除术(en-bolc)[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(05): 482-482.
[2] 王浩瑜, 杨拴元, 任彦顺, 阴志强. 两种改良食管空肠吻合术的腹腔镜全胃切除术中临床对比研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(04): 425-428.
[3] 林炳涛, 陈君填. 不同病理类型进展期胃癌患者临床特征及腹腔镜辅助根治术后短期预后的影响因素[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(04): 429-433.
[4] 杨维军, 张文文, 付凯. 单切口腹腔镜下胃癌根治术治疗早中期胃癌的疗效观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(04): 434-437.
[5] 党立力, 张流, 周鹏, 周华友, 赵伟. 保留左结肠动脉(升支)腹腔镜直肠癌全系膜切除术的临床观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(04): 442-445.
[6] 黎伟忠, 黎嘉历, 张映南, 莫灿荣. 改良Glisson鞘外阻断在腹腔镜解剖性左半肝切除术中的应用研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(04): 453-456.
[7] 张腾, 韩威, 冯章东. 肝内胆管结石不同微创手术方式的临床研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(04): 384-387.
[8] 李盼, 张华秦. 不同腹腔镜胆囊切除术治疗胆囊结石的疗效比较研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(04): 388-391.
[9] 吴金柱, 王锐, 朱国栋, 蔡卫华. 吲哚菁绿荧光导航腹腔镜肝右前叶切除术[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(05): 802-802.
[10] 蒋林哲. 腹腔镜胆囊切除+超细胆道镜经胆囊颈管胆道探查术[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(05): 803-803.
[11] 平文俊, 李江涛, 陈国栋. 机器人肝门部胆管癌根治术[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(05): 804-804.
[12] 杨钰泽, 徐家豪, 杨一石, 王明达, 杨田. 肝细胞癌新辅助治疗进展[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(04): 515-521.
[13] 罗臻, 韦鹏程, 孙馨, 李照. 肝细胞癌骨转移研究进展[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(04): 522-527.
[14] 麦吾兰江·麦麦提, 吐尔洪江·吐逊. 低中心静脉压技术及其在腹腔镜肝切除术中应用进展[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(04): 528-535.
[15] 郭兵, 王万里, 何凯, 黄汉生. 腹腔镜解剖性完全左半肝切除术治疗肝内胆管细胞癌[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(04): 639-639.
阅读次数
全文


摘要